1. Home
  2. AAOI vs EVO Comparison

AAOI vs EVO Comparison

Compare AAOI & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAOI
  • EVO
  • Stock Information
  • Founded
  • AAOI 1997
  • EVO 1993
  • Country
  • AAOI United States
  • EVO Germany
  • Employees
  • AAOI N/A
  • EVO N/A
  • Industry
  • AAOI Semiconductors
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • AAOI Technology
  • EVO Health Care
  • Exchange
  • AAOI Nasdaq
  • EVO Nasdaq
  • Market Cap
  • AAOI 1.6B
  • EVO 1.4B
  • IPO Year
  • AAOI 2013
  • EVO 2021
  • Fundamental
  • Price
  • AAOI $37.60
  • EVO $4.15
  • Analyst Decision
  • AAOI Buy
  • EVO Strong Buy
  • Analyst Count
  • AAOI 6
  • EVO 1
  • Target Price
  • AAOI $28.40
  • EVO $7.00
  • AVG Volume (30 Days)
  • AAOI 5.3M
  • EVO 44.8K
  • Earning Date
  • AAOI 11-06-2025
  • EVO 11-05-2025
  • Dividend Yield
  • AAOI N/A
  • EVO N/A
  • EPS Growth
  • AAOI N/A
  • EVO N/A
  • EPS
  • AAOI N/A
  • EVO N/A
  • Revenue
  • AAOI $368,233,000.00
  • EVO $912,894,891.00
  • Revenue This Year
  • AAOI $96.63
  • EVO N/A
  • Revenue Next Year
  • AAOI $62.31
  • EVO $10.78
  • P/E Ratio
  • AAOI N/A
  • EVO N/A
  • Revenue Growth
  • AAOI 77.94
  • EVO N/A
  • 52 Week Low
  • AAOI $9.71
  • EVO $2.84
  • 52 Week High
  • AAOI $44.50
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • AAOI 64.31
  • EVO 63.61
  • Support Level
  • AAOI $28.85
  • EVO $4.05
  • Resistance Level
  • AAOI $37.68
  • EVO $4.27
  • Average True Range (ATR)
  • AAOI 3.13
  • EVO 0.08
  • MACD
  • AAOI 0.51
  • EVO 0.01
  • Stochastic Oscillator
  • AAOI 97.95
  • EVO 73.91

About AAOI Applied Optoelectronics Inc.

Applied Optoelectronics Inc is a provider of fiber-optic networking products, for four networking end-markets; internet data center, CATV, telecom, and FTTH. The Company designs and manufactures a wide range of optical communications products at varying levels of integration, from components, subassemblies, and modules to complete turn-key equipment. Through direct sales personnel, and manufacturing teams in the United States, China, and Taiwan, the company coordinates with customers to determine product design, qualifications, and performance. The Company has manufacturing and research and development facilities located in the U.S., Taiwan, and China.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: